These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 27092912

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M, Karapetsa D, Gennai S, Ramaglia L, Graziani F, Gabriele M.
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [Abstract] [Full Text] [Related]

  • 24. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
    Sher J, Kirkham-Ali K, Luo JD, Miller C, Sharma D.
    J Oral Implantol; 2021 Jun 01; 47(3):249-268. PubMed ID: 32699903
    [Abstract] [Full Text] [Related]

  • 25. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B, Muschitz Ch, Gruber R, Brandtner Ch, Svejda Ch, Gasser RW, Santler G, Dimai HP.
    Wien Med Wochenschr; 2016 Feb 01; 166(1-2):68-74. PubMed ID: 26847441
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?
    Troeltzsch M, Cagna D, Stähler P, Probst F, Kaeppler G, Troeltzsch M, Ehrenfeld M, Otto S.
    J Craniomaxillofac Surg; 2016 Dec 01; 44(12):1945-1951. PubMed ID: 27836551
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB.
    Oral Maxillofac Surg Clin North Am; 2015 Nov 01; 27(4):509-16. PubMed ID: 26362367
    [Abstract] [Full Text] [Related]

  • 32. Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report.
    Yamamoto S, Maeda K, Kouchi I, Hirai Y, Taniike N, Yamashita D, Imai Y, Takenobu T.
    J Oral Implantol; 2018 Oct 01; 44(5):359-364. PubMed ID: 29870295
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A, Bartold M, Sambrook P, Hawker P.
    J Oral Maxillofac Surg; 2010 Feb 01; 68(2):337-43. PubMed ID: 20116705
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review.
    Seki K, Namaki S, Kamimoto A, Hagiwara Y.
    J Oral Implantol; 2021 Dec 01; 47(6):502-510. PubMed ID: 33270837
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.